MindMazeOne of the ways The BART Foundation fulfills our mission is by carefully watching global research and clinical trial outcomes and sharing that information, in user-friendly language, with the TBI/ABI community.

While neuro-animation experiences such as MindPod are not included in the therapies the BART Foundation currently advocates for, technology tools that offer a cognitive challenge, motor skill training, and a cardiovascular workout are worthy of attention and consideration for those with TBI/ABI. Here’s a little information about the upcoming research study and links to the full article. We’re looking forward to reading the study outcomes!

MindMaze, a company focused on digital therapeutics (DTx) for neurological recovery and care, has partnered with The University of Auckland for a new interventional study exploring the merits of early, immersive, and intensive intervention to recover movement for patients who have experienced a stroke. The Phase 2 trial, Enhancing Spontaneous Recovery After Stroke Study (ESPRESSo, ACTRN12620000871943), will evaluate the effect of MindMaze’s MindPod in a three-week program of high-intensity, high-dose exploratory arm and hand movements initiated within two weeks of stroke on upper limb motor capacity.

MindPod is a neurorestorative solution focusing on brain repair through high intensity and high dose complex exploratory movements. It is an immersive, location-based animated gaming environment that includes customized sound, lighting, and movement tracking. Based on technology developed in the Johns Hopkins University School of Medicine’s Department of Neurology, MindPod is evidence-based, protocolized, FDA-listed, and CE-Marked.

“Research shows that an injured brain can get better, especially if the recovery work starts early. MindPod was designed with this knowledge in mind and the result is a high-dose, high-intensity solution that patients actually enjoy using,” said John Krakauer, M.A., M.D., Professor of Neurology, Johns Hopkins University School of Medicine and Chief Medical Advisor to MindMaze. “This immersive, reinforcing environment is key for motivation and therapy adherence, each of the utmost importance in particular in early recovery settings when morale is most challenged.”

The full article, along with supporting links, can be found on the BuisnessWire website.